TB Clinical Trial
Official title:
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI) and the Influence of Previous BCG Vaccination - Pilot Study
TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG vaccine.
The goal of this project is the verification of current cytometric panel of detection antibodies in a wider panel of stimulative immunodominant antigens for CD4+ and CD8+ T cells in combination with adjuvants 2 in a in vitro activating test. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04645836 -
Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'.
|
N/A | |
| Completed |
NCT00480454 -
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
|
Phase 1 | |
| Active, not recruiting |
NCT03208725 -
Childhood Acute Illness and Nutrition Network
|
||
| Completed |
NCT00480688 -
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT01055145 -
Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients
|
Phase 3 | |
| Completed |
NCT00480714 -
A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers
|
N/A | |
| Active, not recruiting |
NCT04298905 -
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
|
N/A | |
| Completed |
NCT00480558 -
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
|
Phase 1 | |
| Withdrawn |
NCT00424684 -
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
|
N/A | |
| Completed |
NCT00654316 -
Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine
|
Phase 1 | |
| Active, not recruiting |
NCT05405296 -
Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)
|